Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma

Uveal melanoma, the most common primary ocular malignancy in adults, carries a poor prognosis: 50% of patients develop the metastatic disease with a 10–25% 1-year survival and no established standard of care treatment. Prior studies of melphalan percutaneous hepatic perfusion (M-PHP) have shown prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, Sachin, Gibson, Tom, Vigneswaran, Ganesh, Patel, Shian, Wheater, Matthew, Karydis, Ioannis, Gupta, Sanjay, Takhar, Arjun, Pearce, Neil, Ottensmeier, Christian, Stedman, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles: Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893121/
https://www.ncbi.nlm.nih.gov/pubmed/35254333
http://dx.doi.org/10.1097/CMR.0000000000000806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893121/
https://www.ncbi.nlm.nih.gov/pubmed/35254333
http://dx.doi.org/10.1097/CMR.0000000000000806

Ejemplares similares